it's not a recurring revenue like a a daily pill. One payment every ten years per person is pretty meager.
That's for a specific type of male contraceptive, not a general one. Furthermore, there already exist female contraceptive options that last years, so I'm not sure your argument is valid in any case.
Wait, what? Couldn't you interpret that as a new company/startup entering an existing market? "Little economical incentive for Samsung to cannibalize on Apple's market."